What is the mortality and morbidity associated with monoclonal gammopathy of undetermined significance (MGUS)?

Updated: Dec 29, 2019
  • Author: Suzanne R Fanning, DO; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Patients with MGUS tend to do well when treated conservatively. [18] Regular surveillance is required to assess for progression to either a lymphoproliferative disorder or to MM. [19] This risk has been quantified at 1% per year. [20]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!